Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
Why Is Lichen International Limited (LICN) Stock Down -33.64% Today?

Why Is Lichen International Limited (LICN) Stock Down -33.64% Today?

Key Takeaways

  • Shares of LICN fell 33.64% to $0.0146, down from a prior close of $0.0220, and printed a record intraday low of $0.0142.
  • The immediate catalyst was the company's November 18 pre-market release confirming the effective date and ratio of a 1-for-100 reverse stock split, set to take effect at the opening bell on November 20.
  • A secondary and arguably larger driver is the dilution overhang from a $3.5 million registered direct offering priced November 10, whose warrants can be converted into up to roughly 82.6 million additional Class A shares.
  • The selloff was company-specific: the Nasdaq-100 proxy traded modestly lower on the session, so broad market sentiment explains only a fraction of the decline.
  • News Significance Score: 46/100 — Moderate verified news met a move nearly five times the stock's typical daily swing.
  • Traders will watch the first split-adjusted session on November 20, whether the adjusted price can hold near the $1 minimum bid threshold, and any new warrant-related share issuance.
  • For deeper research, explore Price Targets, Earnings, and Forecast pages for detailed data and modeling.
  • Investors tracking systematic strategies can review Trending AI Robots for the strongest performing automated strategies right now.

Opening Summary

Lichen International Limited (LICN) is a Cayman Islands-incorporated holding company that operates in China through its Xiamen-based subsidiaries, providing financial and taxation advisory services, education support services, and financial software and maintenance to listed companies, state-owned enterprises and small businesses. It has traded on the Nasdaq Capital Market since February 2023 and was formerly known as Lichen China Limited. In Wednesday's session, the stock dropped 33.64% to $0.0146 from the previous close of $0.0220, a decline of $0.0074 that left shares at an all-time low. The move was unambiguously negative and followed the company's confirmation that a 1-for-100 reverse stock split takes effect at the open on November 20, layered on top of severe dilution from a financing completed a week earlier.

Reverse Split Confirmed for November 20

In a pre-market announcement, Lichen set the mechanics of its consolidation: every 100 Class A and Class B ordinary shares will become one share, cutting issued and outstanding Class A stock from roughly 63.8 million to about 638,000 and Class B from 110,000 to 1,100. Par value rises from $0.008 to $0.80, and the shares will trade under a new CUSIP, G5479G124, beginning November 20.

A reverse split does not change any shareholder's economic interest, yet the market treated the news as a negative signal. This is the second extreme consolidation in under two years, following a 200-for-1 split in March 2025, and it cements the impression of a share price that cannot hold its listing standard organically. Consolidations of this magnitude also typically compress the shareholder base and reduce liquidity, which in turn discourages institutional participation. The announcement formalized a move shareholders had already approved on November 9, giving sellers a fresh reason to exit ahead of the mechanical adjustment.

Dilution Overhang From the $3.5 Million Offering

The dominant pressure, however, remains structural. On November 10, Lichen priced a registered direct offering of 17.5 million units at $0.20 per unit, raising roughly $3.5 million in gross proceeds. Each unit paired one Class A share — or a pre-funded warrant in lieu of one — with a warrant to purchase 4.72 Class A shares, exercisable immediately at $0.20 or, critically, on a zero-cash basis.

The math is punishing. Pre-offering, the company had about 16.2 million Class A shares outstanding; full exercise of the warrant package would lift the count toward 116 million. Because holders can convert without paying cash, the effective cost basis of that supply is negligible, and the market has repriced the equity accordingly. Shares have fallen more than 95% since the offering was announced, and Wednesday's session extended that slide rather than reversing it. A November 16 release describing a "dual-driven" investment-plus-services strategy offered no financial detail and did nothing to offset the supply overhang.

Listing Compliance and Delisting Risk

Trading at roughly a cent and a half, LICN sits far below Nasdaq's $1.00 minimum bid requirement. Because the company has already used a reverse split in the recent past, its ability to obtain an additional compliance period under exchange rules is limited, and management has acknowledged that continued listing is not assured. That backdrop amplifies downside momentum: any buyer must underwrite both a dilutive capital structure and the possibility of a delisting event, which suppresses bids and widens spreads in what is already a nano-cap order book.

Market Context and Trading Activity

Turnover was heavy. Roughly 12 million shares had changed hands within the first two hours of trading, more than double the roughly 5.5 million-share 50-day average and about ten times the average of the past 60 sessions. The move was almost entirely idiosyncratic: the Nasdaq-100 proxy slipped only about 0.35% on the day, and specialty business services peers were mixed, so sector and macro conditions explain only a small fraction of the decline.

Technically, the picture is one of uninterrupted capitulation. The stock trades below every major moving average, has broken below any meaningful support, and has set a new 52-week low of $0.0142 against a 52-week high of $9.49 — a drawdown exceeding 99%. There is no evidence of a stabilizing base, and each rally attempt this month has been sold.

News Significance Score

A score of 0 would mean no meaningful news and a move typical for the stock; 100 would mean transformative news and an extreme, rare price move. This event lands at 46 out of 100.

The verified news was moderate in isolation: a procedural reverse-split effective date, set against an unresolved and heavily dilutive warrant structure that is material relative to a sub-$1 million market capitalization, though neither alters the underlying business. The price move, by contrast, was nearly five times the stock's typical daily swing, with only two of the past 60 sessions posting a larger absolute change. Moderate news plus an unusual move produces the mid-range score.

What Comes Next for LICN

Attention now shifts to November 20, when the shares begin trading on a split-adjusted basis near $1.46 if the current price holds — a level that would put the stock marginally above Nasdaq's minimum bid for the first time in months. Whether that level survives the reduced float is the central question. Lichen has not published a date for its next results; as a foreign private issuer it reports semiannually, so the next scheduled update would cover full-year 2026. Investors will also monitor warrant exercises and any further capital raises, the trajectory of the company's investment-led strategy, and PRC regulatory developments affecting China-based issuers. Key risks include continued dilution, liquidity withdrawal after the consolidation, and delisting proceedings.

Trending AI Robots

Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions are surfaced in its curated Trending AI Robots section. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the lineup rotates as conditions change. Reviewing that page is a practical way to see which automated approaches are working in the present tape before committing capital.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LICN

Contributor

Dem Sem's AvatarDem Sem|Expert

LICN's RSI Oscillator sits in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where LICN advanced for three days, in 161 of 184 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

LICN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LICN as a result. In 66 of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for LICN turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In 31 of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LICN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for LICN entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.116) is normal, around the industry mean (5.887). P/E Ratio (0.008) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.221) is also within normal values, averaging (9.907).

The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. LICN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LICN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Industry description

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

Market Cap

The average market capitalization across the Office Equipment/Supplies Industry is 8.05B. The market cap for tickers in the group ranges from 47.27K to 88.84B. CTAS holds the highest valuation in this group at 88.84B. The lowest valued company is KUBR at 47.27K.

High and low price notable news

The average weekly price growth across all stocks in the Office Equipment/Supplies Industry was -7%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -7%. PMEC experienced the highest price growth at 28%, while SMX experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Office Equipment/Supplies Industry was 30%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was 86%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 58
Price Growth Rating: 57
SMR Rating: 73
Profit Risk Rating: 83
Seasonality Score: 7 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry OfficeEquipmentSupplies

Industry
N/A
Address
Hubin North Road
Phone
+86 5925586999
Employees
410
Web
https://www.lichenzx.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.